Skip to main content
. 2010 Jan 20;2010(1):CD003974. doi: 10.1002/14651858.CD003974.pub3

Thomas 2002a.

Methods Design: 2x2 factorial design with an additional randomisation for one arm 
 Purpose: examine the effect of a home based exercise programme on knee pain, and to determine the contribution of the contact with a therapist in explaining the outcome
Participants Patients: out‐patients with knee pain recruited through a postal questionnaire 
 Baseline comparability: yes (age, gender, pain, weight, etc)
Interventions Placebo: tablet with dolomite (calcium and magnesium) twice weekly for two years 
 Untreated: no tablets 
 Experimental: 
 ‐exercise (20‐30 minutes daily, initiated by four 30 minutes' instruction sessions within the first two months in the patients' home, and follow up visits every six months). 
 ‐telephone (monthly telephone contact) 
 (Co‐intervention: no information on use of analgesic drugs)
Outcomes Pain (WOMAC osteoarthritis index, 0 to 20) 
 Knee stiffness 
 Disability 
 General physical function (SF‐36) 
 Hospital anxiety and depression scale 
 Isometric quadriceps muscle strength
Notes Not 1:1 randomisation. Dropout rate: 23.7%. Results not presented for placebo and no‐treatment, but authors provided additional data.
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Low risk 'computer generated lists in permuted blocks of 10, stratified by sex and age'
Blinding? 
 Treatment provider High risk Not described as double‐blind (home based exercise/placebo)
Blinding? 
 Outcome assessor Unclear risk Patient reported outcome (interviewer was blinded)
Incomplete outcome data addressed? 
 All outcomes High risk  
Free of selective reporting? High risk No protocol available. Results not presented for placebo and no‐treatment, but authors provided additional data.
Free of other bias? Low risk  
No signs of variance inequality or skewness? Unclear risk Not relevant (not naturally positive continuous outcomes e.g. change)
Trial size > 49? Low risk N = 156
Clearly concealed allocation + trial size > 49 + drop‐out max 15% High risk